Evasive answers are a red flag
Key interaction considerations: Stimulant-containing supplements (including those with caffeine, synephrine, or yohimbine) should be avoided by people taking monoamine oxidase inhibitors (MAOIs) or with uncontrolled hypertension
Research suggests that berberine supplementation may be an effective complementary therapy for managing Despite these positive findings, many of the studies were conducted in animals, so further research in humans is necessary to better understand the potential role of berberine in GLP-1 secretion
adults, conducted May 28-June 5, 2026, using the probability-based Gallup Panel encompassing all 50 states and the District of Columbia
Semaglutide activates GLP-1 receptors in the brain to regulate appetite and blood sugar, but the timeline for noticing results varies by individual